<DOC>
	<DOCNO>NCT03014869</DOCNO>
	<brief_summary>For moderate AECOPD ( pH &lt; 7.35 ) , several guideline strongly recommend NPPV standard therapy , reduce rate intubation mortality . A previous study show HFNC efficiently improve alveolus ventilation breathe pattern severe AECOPD patient . Therefore , hypothesize HFNC inferior NPPV prevent endotracheal intubation moderate AECOPD patient . To assess hypothesis , perform multicenter , randomize , noninferiority trial HFNV v NPPV moderate AECOPD patient .</brief_summary>
	<brief_title>High Flow Nasal Cannula v NPPV Moderate Chronic Obstructive Pulmonary Disease Exacerbation</brief_title>
	<detailed_description>Recently , many clinical study show HFNC successfully use patient hypoxemic respiratory failure improve comfort , attenuate respiratory failure decrease rate tracheal intubation mortality . Although theoretically HFNC potential ideal treatment AECOPD patient , related clinical research . It still need evaluate safety efficacy HFNC patient AECOPD . For moderate AECOPD ( pH &lt; 7.35 ) , several guideline strongly recommend NPPV standard therapy , reduce rate intubation mortality . A previous study show HFNC efficiently improve alveolus ventilation breathe pattern severe AECOPD patient . Therefore , hypothesize HFNC inferior NPPV prevent endotracheal intubation moderate AECOPD patient . To assess hypothesis , perform multicenter , randomize , noninferiority trial HFNV v NPPV moderate AECOPD patient .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<criteria>AECOPD ; 7.35 &gt; pH≥7.25，PaCO2 &gt; 50 mmHg contraindication NPPV , thick sputum , cough weakness , hemodynamic instability , etc . ; need intubate immediately ; refuse engage study ; severe organ dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>COPD Exacerbation</keyword>
	<keyword>High Flow Oxygen</keyword>
	<keyword>Noninvasive Positive Ventilation</keyword>
	<keyword>moderate</keyword>
</DOC>